TrialHub

📉 The graph says it all: Since 2021, clinical trials in #Russia have taken a nosedive due to geopolitical challenges and uncertainty. But where one door closes, another opens... 🌍 Enter #Armenia, #Kazakhstan, and #Moldova! We’ve been listening to our clients, and we’re excited to announce these countries are now part of TrialHub’s global data set! 🎉 The Why? These regions are stepping up as serious contenders for global clinical research, offering fresh opportunities for trial sites, investigators, and streamlined recruitment strategies. 💡 Now you can access data on ✅ trials ✅ sites ✅ investigators ✅ recruitment rates for these new locations, making it easier to consider them as potential sites for your upcoming studies. 🌍 What other countries do you think could emerge as leading destinations for clinical trials in the near future? Are there any regions you’ve been keeping an eye on? We’d love to hear your thoughts! 👇 #DataDriven #Feasibility

🏅 It's a competitive landscape for CROs out there. Just check out our Newsletter! 📰 With the help of TrialHub's realiable, real-time data, coupled with their expertise and KOLs relationships, Biomapas was able to run an initial feasibility assessment in only 5 business days and win their client's trust by proposing a sound strategy justified by numbers. Read more about the challenges of the First-in-Human (FiH) Phase 1a/b Oncology trial they supported and how the Biomapass team overcame those hurdles. 👇 (Link to the case study in the comments)

🚨 CoLab #1: A Major Shift in Clinical Trials covers key developments shaping the industry: 🔍 RFK Jr. as HHS Secretary - Potential volatility in health markets - Vaccine stock drops - How $2 trillion in US spending cuts could impact clinical trials 📊 Quantifying Patient Burden - Transforming qualitative patient insights into actionable data - Aligning trial protocols with real-world Standard of Care (SoC) - 🎉 TrialHub's Whale Tank Award for our SoC dataset - 🔗 [Frontiers Paper & Case Study] 🎥 Upcoming Webinar - WHO Clinical Trials Guidance - Featuring WHO Chief Scientist, Jeremy Farrar - 🗓️ Dec 13—Register now! 💼 Industry Job Openings - Senior Manager at Novo Nordisk - Director at AbbVie 💡 Pharma’s New R&D Strategy - BeiGene’s in-house clinical operations - CROs pivoting to Functional Service Provider (FSP) models Let’s connect and dive into these trends—comment below! 👇 #ClinicalTrials #ClinicalResearch #HealthCare #Pharma

Patient has disease X and is prescribed drug Y. Right? Not the whole story. How the patient experiences it: > Go to a doctor > Go through a diagnostic process (spanning from 1 hour to 3 months) > Receive a prescription from the doctor (And you’d think that’s the end of the story—but no) > Get the prescription filled > Visit the pharmacy > Pharmacy seeks authorization from insurance > Back & Forth & Back & Forth & Back "This is a significant #patient #burden on the US patient population in trying to navigate access to drugs". Thank you Ella Balasa, for raising this important and sometimes overlooked topic. This isn’t just a U.S. problem. As Maya Zlatanova points out, in many countries, treatment protocols—commonly known as lines of treatment—require patients to stay on a particular therapy until it fails before they can be prescribed something more effective.

🚨 Myth Buster Alert: Patient data is not scarce. But here's the catch: most of it is qualitative. Patient surveys, site interviews, round tables, and long-form medical content. 📊📝 The problem? This rich data often gets overlooked because it’s not actionable. That’s the challenge Boehringer Ingelheim tackled with TrialHub IQ, an AI system powered by NLP and ML algorithms. Together, we turned complex qualitative data into quantitative, actionable insights. 🚀 Here's what this means: 1) fewer costly amendments, 2) less time spent in delays, 3) innovative treatments reaching patients faster. How? It all starts with tailoring the trial to the patients' reality. Want to know how we did it? Dive into our case study. 👇 #AI #ClinicalResearch #PatientData #ClinicalTrials

✨ 🧚♀️ The TrialHub fairies never sleep🧚♂️✨ By far one of the favorite perks for many of our clients is the outstanding #customersupport. There's one reason for it: we truly, truly want to make their lives easier. To us, #clinicaltrials are not just about data - although data is where TrialHub shines. Clinical trials are about people - the #patients they serve as well as the thousands of professionals behind the screen involved in their planning and efficient running. Thank you Annie Roten for giving a name to our Customer Success and Medical team - we all call them the TrialHub Fairies now! #clinicalresearch #CRO #pharma

80% of clinical trials get delayed* 60% of delays due to stringent eligibility criteria And this comes with a hefty cost to the industry AND the patient. Why? We simply fail as an industry to connect the protocol with the patients' reality. We're excited to share that our CEO Maya Zlatanova recently introduced the first-ever automated Standard of Care solution on the Innovation Network Gathering stage! - Where are the eligible patients located? - When and how the patients become eligible? - What motivates the patients to join and stay in the trial? Now you have the answers with a click. Directly from reimbursement authorities. Real-time. Worldwide. Ready to streamline your trial planning? *According to the Tufts Center for the Study of Drug Development

Clinical Trials Horror Stories… 🎃 Happy Halloween! Clinical trials can get scary, especially when protocols are not designed with the patient journey in mind: - Exclusion criteria so strict, they block patients with the very conditions being studied. - Randomized, double-blind, placebo-controlled study in patients with death rate above 40% - Relying on just one site to recruit… And that’s just one protocol... 👻 Have you ever faced a protocol nightmare or felt haunted by the ghost of Standard of Care?

Streamlining Country Feasibility with Real-Time SoC Data 🚀 Advanced Clinical leveraged TrialHub’s Standard of Care module to reduce country feasibility assessment time by 25%! 🕒 By using AI-powered insights and real-time reimbursement data (sourced directly from local reimbursement authorities), they could easily navigate complex global oncology reimbursement landscapes. 🌍 This approach not only built sponsor trust but also fostered repeat business. With dynamic access to local reimbursement insights, Advanced Clinical can now anticipate issues and optimize their strategy, ensuring better outcomes for all stakeholders in the drug development journey. #ClinicalTrials #HealthcareInnovation #OncologyResearch #ReimbursementInsights #StandardOfCare

Barcelona, get ready! 🚀 Daniel & Rali are heading to #SCOPE Europe next week! 🎯 Here’s your checklist when you meet them: ✅ Ask about our new Standard of Care Drug Reimbursement module 💡 ✅ Get your copy of the Trial Teasers game 📝 ✅ Learn about the new EU HTA regulations and their impact on clinical trials 🌍 ✅ Claim your prize for completing the Trial Teasers puzzle 🏆 See you in Barcelona! 🌟